5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.40%
Revenue growth at 75-90% of STERV.HE's 6.33%. Bill Ackman would push for innovation or market expansion to catch up.
-35.41%
Negative gross profit growth while STERV.HE is at 11.24%. Joel Greenblatt would examine cost competitiveness or demand decline.
-61.56%
Negative EBIT growth while STERV.HE is at 2.07%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-61.56%
Negative operating income growth while STERV.HE is at 2.07%. Joel Greenblatt would press for urgent turnaround measures.
-168.70%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-168.65%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-168.65%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.13%
Share change of 0.13% while STERV.HE is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
0.13%
Slight or no buyback while STERV.HE is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
-8.86%
Negative OCF growth while STERV.HE is at 21.36%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-18.92%
Negative FCF growth while STERV.HE is at 107.78%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
0.64%
Positive 10Y revenue/share CAGR while STERV.HE is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
9.32%
Positive 5Y CAGR while STERV.HE is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
-8.73%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-109.17%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-128.66%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-106.39%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-152.24%
Negative 10Y net income/share CAGR while STERV.HE is at 4299.89%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-125.37%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-111.03%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
103.75%
10Y equity/share CAGR in line with STERV.HE's 110.75%. Walter Schloss might see both benefiting from stable profitability and moderate payout ratios over the decade.
39.08%
5Y equity/share CAGR at 50-75% of STERV.HE's 59.73%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
11.68%
3Y equity/share CAGR at 50-75% of STERV.HE's 16.59%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
193.55%
Stable or rising dividend while STERV.HE is cutting. John Neff sees a strong advantage in consistent shareholder returns vs. a struggling peer.
-11.88%
Negative 5Y dividend/share CAGR while STERV.HE stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-4.37%
Negative near-term dividend growth while STERV.HE invests at 172.41%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
14.48%
AR growth well above STERV.HE's 6.50%. Michael Burry fears inflated revenue or higher default risk in the near future.
1.28%
Inventory growth well above STERV.HE's 0.54%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-1.36%
Negative asset growth while STERV.HE invests at 0.11%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-0.26%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
8.90%
Debt growth of 8.90% while STERV.HE is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
No Data
No Data available this quarter, please select a different quarter.
9.92%
We expand SG&A while STERV.HE cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.